Sinco Pharmaceuticals Holdings Ltd
HKEX:6833
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sinco Pharmaceuticals Holdings Ltd
HKEX:6833
|
CN |
|
I
|
Incheon City Gas Co Ltd
KRX:034590
|
KR |
|
B
|
Bytetravel SA
MAD:SCBYT
|
ES |
Sinco Pharmaceuticals Holdings Ltd
Sinco Pharmaceuticals Holdings Ltd. engages in the marketing, promotion, and channel management services for pharmaceutical products and medical devices. The company is headquartered in Chengdu, Sichuan and currently employs 120 full-time employees. The company went IPO on 2016-03-10. The company provides its integrated MPCM services to small- and medium-sized overseas pharmaceutical manufacturers that do not possess independent marketing and promotion capabilities in China. Its major product is human albumin solution, a human albumin product manufactured by Octapharma, which is used to remedy hypovolemia and hypovolemic shock, abnormally high intracranial pressure, edema and ascites, and to prevent and cure hypoalbuminemia and neonatal hyper-bilirubinemia. In addition, its products include axetine, medocef, esafosfina, tad and taurolite.
Sinco Pharmaceuticals Holdings Ltd. engages in the marketing, promotion, and channel management services for pharmaceutical products and medical devices. The company is headquartered in Chengdu, Sichuan and currently employs 120 full-time employees. The company went IPO on 2016-03-10. The company provides its integrated MPCM services to small- and medium-sized overseas pharmaceutical manufacturers that do not possess independent marketing and promotion capabilities in China. Its major product is human albumin solution, a human albumin product manufactured by Octapharma, which is used to remedy hypovolemia and hypovolemic shock, abnormally high intracranial pressure, edema and ascites, and to prevent and cure hypoalbuminemia and neonatal hyper-bilirubinemia. In addition, its products include axetine, medocef, esafosfina, tad and taurolite.
